Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Luminex Corporation    LMNX   US55027E1029

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/14/2014 10/15/2014 10/16/2014 10/17/2014 10/20/2014 Date
21.1(c) 19.52(c) 19.25(c) 19.32(c) 19.47(c) Last
298 504 547 941 640 354 454 627 327 529 Volume
+1.01% -7.49% -1.38% +0.36% +0.78% Change
More quotes
Company
Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries.It operates its business through two segments: Technology & Strategic Partnerships, and Assays & Related Products.The... 
Surperformance© rating of Luminex Corporation
Trading Rating : Investor Rating :
More about the company
Chart LUMINEX CORPORATION
Duration : Period :
Luminex Corporation Technical Analysis Chart | LMNX | US55027E1029 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 230 M
EBIT 2014 30,8 M
Net income 2014 20,6 M
Finance 2014 103 M
Yield 2014 -
Sales 2015 253 M
EBIT 2015 36,5 M
Net income 2015 23,0 M
Finance 2015 132 M
Yield 2015 -
PER 2014 39,84
PER 2015 31,41
EV / Sales 2014 3,15x
EV / Sales 2015 2,75x
Capitalization 826 M
More Financials
Latest news on LUMINEX CORPORATION
17h ago LUMINEX : Change in Directors or Principal Officers, Regulation FD Disclosure, F..
4d ago LUMINEX : Announces Retirement of Patrick Balthrop, President and CEO
5d ago LUMINEX : Announces Retirement of Patrick Balthrop, President and CEO
10/13 LUMINEX : Third Quarter Earnings Release Scheduled for October 27, 2014
10/07 LUMINEX : Assigned Patent
10/02 LUMINEX : FDA Clears Luminex to Add Clinical Targets
09/29 LUMINEX : Receives FDA Clearance To Add New Clinical Targets And Additional Samp..
09/05 LUMINEX : To Present At Morgan Stanley Global Healthcare Conference
08/28 LUMINEX : Presolicitation Notice - 70-- Intent to Sole Source
08/28 LUMINEX : to Participate at Global Healthcare Conference
08/25 LUMINEX : To Present At Morgan Stanley Global Healthcare Conference
08/25 LUMINEX : Assigned Patent
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF